SNGX
SNGX
NASDAQ · Biotechnology

Soligenix Inc

$1.13
-0.08 (-6.61%)
Financial Highlights (FY 2026)
Revenue
731.2K
Net Income
-50,633,266
Gross Margin
Profit Margin
-6,925.2%
Rev Growth
-47.4%
D/E Ratio
0.33
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 31.7% 31.7%
Operating Margin -7,907.8% -7,117.0% 16.0% 12.9%
Profit Margin -6,925.2% -6,578.9% 11.6% 16.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 731.2K 1.39M 2.02M 1.51M
Gross Profit 641.3K 476.9K
Operating Income -57,824,461 -98,920,385 323.1K 193.8K
Net Income -50,633,266 -86,618,398 234.8K 245.0K
Gross Margin 31.7% 31.7%
Operating Margin -7,907.8% -7,117.0% 16.0% 12.9%
Profit Margin -6,925.2% -6,578.9% 11.6% 16.3%
Rev Growth -47.4% -47.4% +14.4% +1.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.53M 1.53M 3.18M 3.12M
Total Equity 4.58M 4.58M 9.01M 7.78M
D/E Ratio 0.33 0.33 0.35 0.40
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -56,022,445 -101,161,989 368.8K 310.9K
Free Cash Flow 168.2K 121.5K